Most Popular
1. It’s a New Macro, the Gold Market Knows It, But Dead Men Walking Do Not (yet)- Gary_Tanashian
2.Stock Market Presidential Election Cycle Seasonal Trend Analysis - Nadeem_Walayat
3. Bitcoin S&P Pattern - Nadeem_Walayat
4.Nvidia Blow Off Top - Flying High like the Phoenix too Close to the Sun - Nadeem_Walayat
4.U.S. financial market’s “Weimar phase” impact to your fiat and digital assets - Raymond_Matison
5. How to Profit from the Global Warming ClImate Change Mega Death Trend - Part1 - Nadeem_Walayat
7.Bitcoin Gravy Train Trend Forecast 2024 - - Nadeem_Walayat
8.The Bond Trade and Interest Rates - Nadeem_Walayat
9.It’s Easy to Scream Stocks Bubble! - Stephen_McBride
10.Fed’s Next Intertest Rate Move might not align with popular consensus - Richard_Mills
Last 7 days
Trump's Squid Game America, a Year of Black Swans and Bull Market Pumps - 24th Jan 25
Japan Interest Rate Hike - Black Swan Panic Event Incoming? - 23rd Jan 25
It's Five Nights at Freddy's Again! - 12th Jan 25
Squid Game Stock Market 2025 - 5th Jan 25
Stock Market Bubble Drivers, Crypto Exit Strategy During Musk Presidency - 27th Dec 24
Gold Stocks’ Remain Exceptionally Weak Even as Stocks Rise - 27th Dec 24
Gold’s Remarkable Year - 27th Dec 24
Stock Market Rip the Face Off the Bears Rally! - 22nd Dec 24
STOP LOSSES - 22nd Dec 24
Fed Tests Gold Price Upleg - 22nd Dec 24
Stock Market Sentiment Speaks: Why Do We Rely On News - 22nd Dec 24
Never Buy an IPO - 22nd Dec 24
THEY DON'T RING THE BELL AT THE CRPTO MARKET TOP! - 20th Dec 24
CEREBUS IPO NVIDIA KILLER? - 18th Dec 24
Nvidia Stock 5X to 30X - 18th Dec 24
LRCX Stock Split - 18th Dec 24
Stock Market Expected Trend Forecast - 18th Dec 24
Silver’s Evolving Market: Bright Prospects and Lingering Challenges - 18th Dec 24
Extreme Levels of Work-for-Gold Ratio - 18th Dec 24
Tesla $460, Bitcoin $107k, S&P 6080 - The Pump Continues! - 16th Dec 24
Stock Market Risk to the Upside! S&P 7000 Forecast 2025 - 15th Dec 24
Stock Market 2025 Mid Decade Year - 15th Dec 24
Sheffield Christmas Market 2024 Is a Building Site - 15th Dec 24
Got Copper or Gold Miners? Watch Out - 15th Dec 24
Republican vs Democrat Presidents and the Stock Market - 13th Dec 24
Stock Market Up 8 Out of First 9 months - 13th Dec 24
What Does a Strong Sept Mean for the Stock Market? - 13th Dec 24
Is Trump the Most Pro-Stock Market President Ever? - 13th Dec 24
Interest Rates, Unemployment and the SPX - 13th Dec 24
Fed Balance Sheet Continues To Decline - 13th Dec 24
Trump Stocks and Crypto Mania 2025 Incoming as Bitcoin Breaks Above $100k - 8th Dec 24
Gold Price Multiple Confirmations - Are You Ready? - 8th Dec 24
Gold Price Monster Upleg Lives - 8th Dec 24

Market Oracle FREE Newsletter

How to Protect your Wealth by Investing in AI Tech Stocks

Adult Stem Cells: Investors can Cash in on the New Fountain of Youth

Companies / BioTech Oct 22, 2012 - 08:44 AM GMT

By: Money_Morning

Companies

Best Financial Markets Analysis ArticleMichael A. Robinson writes: It's flat-out amazing how fast the science of adult stem cells is moving.

Just last week, I told you about two scientists who won the 2012 Nobel Prize in Medicine for creating this field.


The advance that cemented their award occurred in 2002. But it wasn't until just five years ago, in 2007, that the science of deriving adult stem cells really began in earnest.

As you might expect, it took two or three years just for all those teams around the world to get organized.

Already, I'm seeing a steady stream of new findings. There seems to be something new almost every week.

As a group, they point to a day in the very near future in which adult stem cells will become a routine part of treating a wide range of diseases, from cancer to Alzheimer's.

See, that's the great thing about stem cells - they can grow to become anything, from bone to brain tissue. Doctors hope to take your own cells, like those in your skin, and use them to grow replacement organs or to repair damaged muscles or other tissue.

Over the weekend, I told you how a team used adult stem cells to reverse vision loss in older mice. As it turns out, there are more advances you should know about.

You will really like this first one...

Adult Stem Cell Breakthrough No. 1: The New Fountain of Youth
At age 20, armed with one of the best male physiques on the planet, Arnold Schwarzenegger became Mr. Universe.

At 65, the action hero still looks good... but he's not nearly as buff.

And how could he be? It's a simple fact of science. As we age, we lose muscle mass, leaving us much more prone to falls and injuries.

Now, a team from the U.S. and Great Britain has found both the cause and a possible cure. Team members looked at stem cells inside muscles of mice. They found that the older mice in the study had far fewer of the stem cells needed to repair damage and rebuild muscle mass.

Here's why.

As the muscles got older, they showed high levels of a protein known as FGF2. That's important because this protein tells cells to divide, and the process continued over time until the muscles run out of stem cells. As that occurred, the muscles slowly withered away.

To stop the pool of stem cells from running out, team members gave the mice a common drug used to inhibit the FGF2 protein. So far, it seems to be working; team members slowed the decline of muscle stem cells in the mice.

"The finding opens up the possibility that one day we could develop treatments to make old muscles young again," said team leader Dr. Albert Basson. "If we could do this, we may be able to enable people to live more mobile, independent lives as they age."
Next, the researchers want to study muscles in older humans. It may take a few years to prove that the stem cells in our human muscles go through the exact same process as in mice. But if that turns out to be the case, the team has a head start on a possible "fountain of youth."

Adult Stem Cell Breakthroughs No. 2 and 3: Fighting Brain Disease
Few diseases attack the brain as ruthlessly as Huntington's Disease.

People who get the hereditary disease start to jerk and twitch, then lose control of their muscles. As HD patients get sicker, they can have severe breaks with reality. And then they die.

At present, there is no way to even slow the disease. Yet 200,000 people in the U.S. alone are at risk of developing it. No wonder research teams are working overtime to come up with a cure.

One team has reported key progress in finding new ways to test drugs that might at least keep the disease at bay. And it's all because of adult stem cells.

The global research team pulled off a fascinating feat. They took skin cells from a young patient and turned them into brain cells that actually had HD. By using adult stem cells to make what they call "HD in a dish," team members took a big step toward learning what kills the brain cells of those who inherit the fatal disease.

"For the first time, we will be able to study how drugs work on human HD neurons and hopefully take those findings directly to the clinic," said Dr. Christopher A. Ross of the Johns Hopkins University School of Medicine.

Now, Ross and his team are starting to test new compounds they hope will become drugs that can slow the progress of HD. Ross thinks this also could help with research into other fatal brain disorders like Alzheimer's and Parkinson's.

Meantime, a team at the Hospital for Sick Children may have found a new way to treat brain disease or injury with a drug that is widely used to treat Type II diabetes.

They found that the drug, metformin, instructs stem cells in the brain to become nerve cells. This is important because both cell types play a vital role in the repair of an injured brain or one breaking down from disease. Thus, the diabetes drug might help those with brain diseases for which there is no treatment.

And there's more good news...

Because metformin is already on the market, doctors may be able to test it on current brain injury cases. And that could cut years off the time it can take to conduct full clinical trials to get approval for use as a brain treatment.

Adult Stem Cell Breakthroughs No. 4 and 5: Making Treatments Healthier
As I told you in parts 1 and 2 of this series, adult stem cells allow us to avoid the whole debate about the ethics of using those that come from embryos.

The adult versions are not without their problems, though.

One big challenge to date is that they also can cause tumors to grow (as do embryonic ones).

But a team from the Mayo Clinic has found a much safer route.

They used chemotherapy in advance to kill off the trouble-making cells. Using mouse models, the Mayo team found that the chemical agent killed off the DNA of the stem cells. The big advance here is that the process killed the cells that cause tumors but left the healthy cells intact.

They still need to do more tests, but team members believe this could be one way to start making adult stem cells a safe treatment for patients.

Meantime, a team at the University of Michigan has come up with a way to grow adult stem cells that the body won't reject. And to think - it's all thanks to a synthetic gel that coats a petri dish.

This gel allows the stem cells to grow without any type of contaminants getting into the dish. That means nothing can get in that could disrupt the growth of the adult stem cells.

Team members turned those cells into ones for fat, cartilage, and bone. Mice that got the treatment had 4.2 times as much bone as those that didn't - and all without any attempt by their bodies to reject the transplanted cells.

I predict that adult stem cells will play a big role in what is going to be a very bright future. This field could be a real boon to improving the health of the entire human race. I believe we are not far from the day when we could all live to 100... and, more to the point, enjoy it.

In the meantime, I'm keeping an eye out for an investment opportunity in the field.

Because no doubt it will make investors very rich, too.

Source :http://moneymorning.com/2012/10/22/adult-stem-cells-cashing-in-on-the-new-fountain-of-youth/

Money Morning/The Money Map Report

©2012 Monument Street Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Monument Street Publishing. 105 West Monument Street, Baltimore MD 21201, Email: customerservice@moneymorning.com

Disclaimer: Nothing published by Money Morning should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investent advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication, or after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Money Morning should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Money Morning Archive

© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in